1

SHL Telemedicine

SHL Telemedicine
Leadership team

Mr. Erez Nachtomy (CEO & Exec. Director)

Mr. Linus Drop (Managing Director of SHL Telemedizin Germany)

Mr. Amir Hai (Chief Financial Officer)

Products/ Services
Medical, Telecommunications
Number of Employees
100 - 500
Headquarters
Tel Aviv, Tel Aviv, Israel
Established
1987
Revenue
20M - 100M
Traded as
SWX:SHLTN
Social Media
Overview
Location
Summary
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. The company offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and collaboration agreement with the Hebrew University of Jerusalem and the Hadassah Medical Center to develop an artificial intelligence tool for predicting future life-threatening cardiac events based on 12 Lead ECG monitoring. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel.
History

SHL Telemedicine was founded in 2013 with a commitment to using technology to improve the healthcare experience for patients and providers. We have grown rapidly, expanding our services and technology to serve more people in more places. We have won numerous awards for our innovative solutions, including the 2020 Digital Health Startup of the Year.

Mission
Our mission is to improve the quality and access of healthcare through technology and to empower people to make informed decisions about their health and healthcare.
Vision
Our vision is to be the premier digital healthcare provider, providing a comprehensive suite of solutions that enable people to manage their health and healthcare needs in a more efficient and effective way.
Key Team

Mr. Erez Nachtomy (CEO & Exec. Director)

Mr. Linus Drop (Managing Director of SHL Telemedizin Germany)

Mr. Amir Hai (Chief Financial Officer)

Recognition and Awards
2020 Digital Health Startup of the Year, Entrepreneur 360 List, Red Herring Top 100 North America Award
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

SHL Telemedicine
Leadership team

Mr. Erez Nachtomy (CEO & Exec. Director)

Mr. Linus Drop (Managing Director of SHL Telemedizin Germany)

Mr. Amir Hai (Chief Financial Officer)

Products/ Services
Medical, Telecommunications
Number of Employees
100 - 500
Headquarters
Tel Aviv, Tel Aviv, Israel
Established
1987
Revenue
20M - 100M
Traded as
SWX:SHLTN
Social Media